Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.

Exaggerated production of various proteases may account for the late presence of organ dysfunction in acute pancreatitis. This study examined the effects of early administration of gabexate mesilate on the condition of patients with severe acute pancreatitis and organ dysfunctions.
Fifty-two patients with acute pancreatitis and organ dysfunction were enrolled. The treatment group included 26 patients receiving intravenous gabexate mesilate infusion at a dose of 100 mg/hr for 7 days. APACHE-II score, clinical and biochemical parameters were monitored intensively.
Coagulopathy ileus, and abdominal pain was significantly improved with gabexate mesilate. Gabexate mesilate reduced the necessity for surgical intervention and peritoneal lavage. The 7-day-mortality and 90-day-mortality rates were also significantly reduced with gabexate mesilate therapy.
There are strong indications from this study that early intravenous gabexate mesilate infusion results in improved survival in acute pancreatitis with organ dysfunctions.
AuthorsH M Chen, J C Chen, T L Hwang, Y Y Jan, M F Chen
JournalHepato-gastroenterology (Hepatogastroenterology) 2000 Jul-Aug Vol. 47 Issue 34 Pg. 1147-50 ISSN: 0172-6390 [Print] GREECE
PMID11020900 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Serine Proteinase Inhibitors
  • Gabexate
  • Adult
  • Female
  • Gabexate (therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Multiple Organ Failure (drug therapy)
  • Pancreatitis, Acute Necrotizing (drug therapy)
  • Prospective Studies
  • Serine Proteinase Inhibitors (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: